Uždaroji akcinė bendrovė "CHEMI PHARM GROUP" Finance - revenue, profit
Financial ratios
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 598,399 |
| 99,733 |
| 52,801 |
| 44,195 |
| 7,366 |
| 33.57 |
| 7.39 |
| 300,441 |
| 39,937 |
| 24,216 |
| 316,162 |
| 2024 |
|---|
| 739,711 |
| 123,285 |
| 30,670 |
| 21,311 |
| 3,552 |
| 32.17 |
| 2.88 |
| 255,936 |
| 29,860 |
| 20,103 |
| 265,693 |
| 2025 |
|---|
| 715,504 |
| 119,251 |
| 14,414 |
| 11,343 |
| 1,891 |
| 17.20 |
| 1.59 |
| 214,929 |
| 39,485 |
| 17,885 |
| 236,529 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 715,504 |
| 119,251 |
| 14,414 |
| 11,343 |
| 1,891 |
| 17.20 |
| 1.59 |
| 214,929 |
| 39,485 |
| 17,885 |
| 236,529 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
715,504 €-3 % *
Sales per employee (€)
119,251 €-3 % *
Profit before tax (€)
14,414 €-53 % *
Net Profit (€)
11,343 €-47 % *
Profit per employee (€)
1,891 €-47 % *
Total profitability (%)
17.20 %-46.53 % *
Net profitability (%)
1.59 %-44.79 % *
Equity (€)
214,929 €-16 % *
Amounts Payable And Liabilities (€)
39,485 €32 % *
Non-current Assets (€)
17,885 €-11 % *
CurrentAssets (€)
236,529 €-11 % *
